
Russia Gives First Patient Personalized Cancer Vaccine
A 60-year-old melanoma patient in Moscow just received Russia's first personalized mRNA cancer vaccine, designed specifically for their tumor. The breakthrough treatment trains the immune system to target cancer cells unique to each patient.

